According to the report published by Allied Market Research, the global hemostats market generated $2.8 billion in 2021, and is projected to reach $4.7 billion by 2031, witnessing a CAGR of 5.3% from 2022 to 2031. The report provides a detailed analysis of changing market dynamics, top segments, value chain, key investment pockets, regional scenario, and competitive landscape.
Download Sample Report- https://www.alliedmarketresearch.com/request-sample/17218
Key Market Players
Baxter International Inc., B.Braun Melsungen AG, Becton Dickinson and Company, Hemostatis LLC, Integra Life Sciences Holding Corporation, Johnson and Johnson, Medtronic Plc, Pfizer Inc., Stryker Corporation, Teleflex Incorporated
By Type
- Thrombin Based Hemostats
- Oxidized Regenerated Cellulose Based Hemostats
- Combination Hemostats
- Gelatin Based Hemostats
- Collagen Based Hemostats
- Others
By Formulation
- Sheet and Pad Hemostats
- Sponge Hemostats
- Powder Hemostats
- Others
- Matrix and Gel Hemostats
By Application
- Orthopedic Surgery
- General Surgery
- Neurological Surgery
- Cardiovascular Surgery
- Reconstructive Surgery
- Gynecological Surgery
- Others
Get detailed COVID-19 impact analysis on the Hemostats Market – https://www.alliedmarketresearch.com/request-for-customization/17218?reqfor=covid